A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...

Stereotactic body radiation therapy (SBRT), defined as the delivery of >5Gy per fraction, has emerged as a well-established standard of care option for the definitive management of localized prostate ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, ...

RADX READ THE FULL RADX RESEARCH REPORT Radiopharm Theranostics Limited (NASDAQ:RADX) held another key opinion leader (KOL) ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...

Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim ...

The 67 th American Society for Radiation Oncology (ASTRO) annual meeting held in San Francisco., between September 28 and September 30 was host to the Session16 - GU 4: Quality of Life Outcomes after ...

In a clinical practice guideline published online Sept. 16 in Practical Radiation Oncology, recommendations are presented for ...

Scintillators convert radiation energy into light and are utilized in a variety of fields including medicine and security. Of ...